Health Cidara Therapeutics and Melinta Therapeutics Announce FDA Approval of REZZAYO™ … Eli Pacheco Mar 23, 2023 0 <!-- Name:DistributionId Value:8793824 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Health FDA Panel Backs Weekly Rezafungin for Candidemia, Invasive Candidiasis Eli Pacheco Jan 26, 2023 0 An FDA advisory committee on Tuesday overwhelmingly recommended approval, with a "limited…
Health SCYNEXIS Presents Data Analyses Showing Ibrexafungerp’s Potential to Fight Invasive… Eli Pacheco Apr 27, 2022 0 New interim analysis of the Phase 3 CARES study showed complete or partial response in 78% of the 18 patients treated with ibrexafungerp for infections caused by Candida auris, a…